(Q34629445)

English

Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

0 references

1 reference

Europe PubMed Central

Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis (English)

1 reference

Europe PubMed Central

3 August 2017

0 references

0 references

1

object named as

Bruce Arroll

1 reference

Europe PubMed Central

3 August 2017

object named as

Frank Sullivan

5

0 references

object named as

Brian Williams

6

0 references

author name string

Steve Macgillivray

2

1 reference

Europe PubMed Central

3 August 2017

Simon Ogston

3

1 reference

Europe PubMed Central

3 August 2017

Ian Reid

4

1 reference

Europe PubMed Central

3 August 2017

Iain Crombie

7

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

3 August 2017

Annals of Family Medicine

1 reference

Europe PubMed Central

3 August 2017

3

1 reference

Europe PubMed Central

3 August 2017

5

1 reference

Europe PubMed Central

3 August 2017

449-456

1 reference

Europe PubMed Central

3 August 2017

Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

Review: venlafaxine is more effective than selective serotonin-reuptake inhibitors for depression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

Effectiveness of teaching general practitioners skills in brief cognitive behaviour therapy to treat patients with depression: randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

Meta-analytical studies on new antidepressants.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

Efficacy of newer medications for treating depression in primary care patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

A systematic review of newer pharmacotherapies for depression in adults: evidence report summary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

The Norwegian naturalistic treatment study of depression in general practice (NORDEP)-I: randomised double blind study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

The effects of detection and treatment on the outcome of major depression in primary care: a naturalistic study in 15 cities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

Efficacy of venlafaxine in depressive illness in general practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

Prescribing antidepressants in general practice. Systematic review of all pertinent trials is required to establish guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

A double-blind, placebo-controlled comparison of sertraline and dothiepin in the treatment of major depression in general practice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

Controlled trial of amitriptyline in general practice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

Double-blind placebo-controlled trial of amitriptyline among depressed patients in general practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

A placebo-controlled multicenter trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

7 July 2018

Treating depression: the beyondblue guidelines for treating depression in primary care. "Not so much what you do but that you keep doing it".

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

26 October 2018

Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

26 October 2018

Management of patients with depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

26 October 2018

Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

26 October 2018

Symptom profiles of depression among general medical service users compared with specialty mental health service users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1466912

26 October 2018

Is primary care essential?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16189062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16189062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidepressant treatment of depression: a metaanalysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16189062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of antidepressant treatment on the quality of daily life: an experience sampling study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16189062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression in patients in an Auckland general practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/16189062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1370/AFM.349

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34629445&oldid=1953225610"